Champions Oncology (CSBR) Net Equity Issued and Repurchased (2016)

Champions Oncology (CSBR) posted quarterly Net Equity Issued and Repurchased of $4.3 million for Q3 2016.

Champions Oncology (CSBR) Net Equity Issued and Repurchased (2016) Analysis & Trends

Champions Oncology's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $4.3 million for Q3 2016.

In Q3 2016, Net Equity Issued and Repurchased changed N/A year-over-year to $4.3 million; the TTM figure through Apr 2017 stood at $4.3 million (changed N/A YoY), while the FY2017 annual figure was $4.3 million, changed N/A from the prior year.
Net Equity Issued and Repurchased for Q3 2016 stood at $4.3 million.
The five-year high for Net Equity Issued and Repurchased was $4.3 million in Q3 2016, with the low at $4.3 million in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Champions Oncology	68.61 Mn	68.61 Mn	7.03 Mn	-

Download Data

Date	Value
Jul 31, 2016	4.34 Mn
Jul 31, 2016	4.34 Mn